← Eichor
Study identifier: NCT07042321 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Risk Factors for Microvascular Obstruction Post-Emergency PCI in AMI Patients

Condition: Acute Myocardial Infarction (AMI)  ·  Sponsor: The Third Xiangya Hospital of Central South University

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this prospective cohort study is to investigate the relationship between the TyG index and early identification of MVO in AMI patients undergoing emergency PCI and CMR imaging. The study will enroll approximately 300 AMI patients treated at Xiangya Third Hospital of Central South University from June 2024 to August 2025. The main questions it aims to answer are: * How does the TyG index correlate with the early detection of MVO? * What differences in cardiovascular adverse events during hospitalization exist between groups with varying TyG index levels? Participants will undergo emergency PCI and CMR imaging within 3-7 days post-procedure. Data collected will include demographic characteristics, clinical history, coronary angiography data, laboratory test indicators (especially metabolic markers such as blood glucose and lipids), IVUS-related plaque information, and CMR results.

This description comes directly from the study's public registry record.

Talk to the study team

can Zhu Can  ·  +8613348674820  ·  zhucan1021@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Xiangya Third Hospital of Central South UniversityChangsha, Hunan Province,China, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07042321